Related Experiment Video
Updated: Jun 30, 2026

09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
9.1K
Evaluating a Tri-Institutional Cancer Research Capacity-Building Program for Early-Stage Investigators
Kathryn S Maxwell1, Lecarde Webb2, Desiree Rivers3
1University of Alabama at Birmingham, Birmingham, AL, UK. ksmaxwell@uabmc.edu.
Summary
The Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) program successfully trains early-stage investigators (ESIs) and postdoctoral fellows. Structured training and mentorship significantly boost cancer research careers, particularly at under-resourced institutions.
Area of Science:
- Cancer Health Equity Research
- Investigator Training and Development
- Health Disparities in Oncology
Background:
- The National Cancer Institute's (NCI) Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) initiative fosters collaborations between under-resourced institutions and NCI-designated Cancer Centers.
- Long-standing partnerships aim to enhance cancer research capacity and workforce development.
- The Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center partnership is a key CPACHE program focused on investigator training.
Purpose of the Study:
- To evaluate the longitudinal impact of a year-long research education program for early-stage investigators (ESIs) and postdoctoral fellows.
- To assess the program's effectiveness in building cancer research skills, enhancing mentorship, and supporting career development.
- To provide insights for optimizing similar training programs for investigators at under-resourced institutions.
Main Methods:
- Analysis of administrative records from the Research Education Core for scholars and mentors.
- Utilized Scopus and PubMed databases to track publications.
- Employed NIH RePORTER database to identify grant funding acquisition.
Main Results:
- Nearly 95% of 89 program scholars achieved at least one publication.
- 70% of scholars had a first-author publication, and 62% had a senior-author publication.
- Approximately 20% of scholars secured NIH funding as principal investigators.
Conclusions:
- The tri-institutional training program effectively attracts and supports investigators committed to cancer research.
- Structured training, intensive mentorship, and cross-institutional collaboration significantly contribute to academic career advancement.
- Findings offer valuable insights for enhancing investigator development programs, especially for ESIs and postdoctoral fellows at under-resourced institutions.
Related Concept Videos
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

